Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. FDA Record
Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. has 0 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd." is on file.
- Latest inspection
- Oct 31, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 4 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 31, 2025 | Taizhou, China | Veterinary | No Action Indicated (NAI) | 3006545436 |
| Nov 2, 2017 | Taizhou, China | Drugs | No Action Indicated (NAI) | 3006545436 |
| Jul 8, 2016 | Taizhou, China | Veterinary | Voluntary Action Indicated (VAI) | 3006545436 |
| Sep 26, 2014 | Taizhou, China | Veterinary | Voluntary Action Indicated (VAI) | 3006545436 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006545436 | Taizhou, China | 4 | Oct 31, 2025 |
Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. and the FDA: common questions
Has Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.?
The most recent FDA inspection on file ended Oct 31, 2025 at Taizhou, China and was classified NAI. FDA has 4 inspections of Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. on file.
Need more than this page shows? Ask about Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.